ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC12531-100mg |
|
1140909-48-3 |
Cabozantinib malate (XL184)
|
0 | C32H30FN3O10 | |
GC12531-25mg |
|
1140909-48-3 |
Cabozantinib malate (XL184)
|
0 | C32H30FN3O10 | |
GC12531-5mg |
|
1140909-48-3 |
Cabozantinib malate (XL184)
|
0 | C32H30FN3O10 | |
GC12530-50mg |
|
— |
PFI-2 (hydrochloride)
|
0 | C23H26ClF4N3O3S | |
GC12530-25mg |
|
— |
PFI-2 (hydrochloride)
|
0 | C23H26ClF4N3O3S | |
GC12530-5mg |
|
— |
PFI-2 (hydrochloride)
|
0 | C23H26ClF4N3O3S | |
GC12530-10mM (in 1mL DMSO) |
|
— |
PFI-2 (hydrochloride)
|
0 | C23H26ClF4N3O3S | |
GC12528-50mg |
|
18711-16-5 |
NS309
|
0 | C8H4Cl2N2O2 | |
GC12528-5mg |
|
18711-16-5 |
NS309
|
0 | C8H4Cl2N2O2 | |
GC12527-10mM (in 1mL DMSO) |
|
110044-82-1 |
Calpain Inhibitor I, ALLN
|
0 | C20H37N3O4 | |
GC12527-25mg |
|
110044-82-1 |
Calpain Inhibitor I, ALLN
|
0 | C20H37N3O4 | |
GC12527-5mg |
|
110044-82-1 |
Calpain Inhibitor I, ALLN
|
0 | C20H37N3O4 | |
GC12526-5mg |
|
25683-07-2 |
Pyoluteorin
|
0 | C11H7Cl2NO3 | |
GC12526-1mg |
|
25683-07-2 |
Pyoluteorin
|
0 | C11H7Cl2NO3 | |
GC12525-5g |
|
2181-04-6 |
Potassium Canrenoate
|
0 | C22H29KO4 | |
GC12525-1g |
|
2181-04-6 |
Potassium Canrenoate
|
0 | C22H29KO4 | |
GC12524-50mg |
|
864741-95-7 |
SB 699551
|
0 | C34H45N3O.2HCl | |
GC12524-10mg |
|
864741-95-7 |
SB 699551
|
0 | C34H45N3O.2HCl | |
GC12523-50mg |
|
313397-13-6 |
Reversan
|
0 | C26H27N5O2 | |
GC12523-10mg |
|
313397-13-6 |
Reversan
|
0 | C26H27N5O2 | |